Revance Therapeutics
RVNC
#7444
Rank
HK$2.50 B
Marketcap
HK$24.01
Share price
0.65%
Change (1 day)
-64.13%
Change (1 year)

Revance Therapeutics (RVNC) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$4.85 Billion

According to Revance Therapeutics's latest financial reports the company's total liabilities are HK$4.85 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Revance Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$4.92 B10.63%
2022-12-31HK$4.44 B23.29%
2021-12-31HK$3.60 B34.54%
2020-12-31HK$2.68 B199.95%
2019-12-31HK$0.89 B41.43%
2018-12-31HK$0.63 B201.3%
2017-12-31HK$0.20 B-0.85%
2016-12-31HK$0.21 B20.97%
2015-12-31HK$0.17 B40.08%
2014-12-31HK$0.12 B-91.06%
2013-12-31HK$1.39 B-21.67%
2012-12-31HK$1.78 B17.54%
2011-12-31HK$1.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$23.72 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$840.17 B 17,211.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$92.88 B 1,813.93%๐Ÿ‡บ๐Ÿ‡ธ USA